Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot study.
Gaartman AE, Beuger BM, de Ligt LA, Veldthuis M, Matlung HL, Meijers JCM, Schalkwijk CG, de Heer K, Heijmans J, van Zwieten R, Biemond BJ, van Bruggen R, Nur E.
Gaartman AE, et al.
Br J Haematol. 2024 Dec 6. doi: 10.1111/bjh.19943. Online ahead of print.
Br J Haematol. 2024.
PMID: 39639778
No abstract available.